Introduction
The disaccharide lactose is the main carbohydrate in milk; it is composed of glucose and galactose bound in a b-glycosidic linkage. The hydrolysis of these components in the intestinal lumen is achieved by a specific enzyme, lactase-phlorizin hydrolase (LPH), and precedes transport of glucose and/or galactose across the brush border membrane (Grand et al., 2003) .
The expression of LPH in adults is polymorphic with large differences in allele frequency among human populations (Sahi, 1994; Kozlov et al., 1998) . Enzyme levels are highest shortly after birth and decline after weaning and with aging independently of a continued lactose intake (Flatz, 1987) . However, in many individuals high lactase expression persists into adult life (Swallow, 2003) .
Lactase persistence tends to be the most frequent phenotype in populations where fresh milk forms a significant part of the adult diet, like Northern Europeans and some pastoral nomadic tribes (Swallow, 2003) . Lactase non-persistent adults may experience abdominal bloating, abdominal pain, flatulence and diarrhoea after the ingestion of fresh milk. However, it has been reported that lactose malabsorbers can ingest up to two cups of milk without symptoms indicating that other factors besides lactase persistence may play a role in determining clinical presentation (Suarez et al., 1998) .
A strong association between lactase activity evaluated by jejunal biopsy in Finnish families and the C/T-13910 polymorphism roughly 14 kb upstream of the lactase gene locus on 2q21 has been found (Enattah et al., 2002) . In addition, studies of LPH gene expression have shown that the molecular difference between lactase persistence and non-persistence is caused by the difference at position À13910 (Olds and Sibley, 2003; Troelsen et al., 2003) . While the T allele in homozygosis as well as in heterozygosis is associated with lactase persistence, the C allele in homozygosis is associated with hypolactasia and its presence is consistent with the reported prevalence of adult-type hypolactasia (Enattah et al., 2002) . Indeed, this genetic typing has been proposed as a screening test for adult type hypolactasia over 12 years of age (Enattah et al., 2002; Rasinpera et al., 2004) .
However, determining the lactase activity in intestinal biopsies may yield results that are largely depending on the site of sampling, thus studies comparing the genetic testing with this parameter may suffer from this caveat (Brummer et al., 1993) .
In addition, in a recent work performed in several African countries, discordant results between the frequency of the lactase persistence phenotype and the prevalence of the T-13910 polymorphism were found (Mulcare et al., 2004 ). In the above study, the genotyping of the C/T-13910 was evaluated by a PCR-RFLP method using DNA extracted from buccal swab in 20 different African populations. As phenotype data was not available for these samples, the authors performed an ethnologically matched group study to determine whether not C/C-13910 was associated with lactase persistence in seven African samples using a statistical procedure to take both sampling and phenotyping error into account. The authors concluded that the C/T-13910 polymorphism is not a predictor of lactase persistence in sub-Saharan Africans and that the C/T-13910 variant, as a diagnostic predictor of adult hypolactasia, should be approached with caution outside Europe (Mulcare et al., 2004) .
Thus, at the present time there is a confusing scenario about this genetic variant and its association with lactase persistence in different geographic areas: that is strong correlation among North-Europeans and weak or no association among sub-Saharan Africans (Mulcare et al., 2004) .
As the Sardinian population is an ancient genetic isolate with a peculiar distribution of alleles at multiple loci and as such offers a unique opportunity for comparative studies on human genome diversity, we wondered if the C/T-13910 variant is present also in our Mediterranean island and if it may be used to predict the malabsorption of lactose as in North-Europeans.
To accomplish this aim, the phenotype of lactose malabsorption and lactose normal absorption was defined by using a combination of different breath hydrogen tests, lactose breath hydrogen test (L-BHT) with 25 g, lactulose breath hydrogen test (La-BHT) and L-BHT with 50 g, and clinical assessment. These phenotypes were compared with the genetic testing result to verify its applicability for adult type hypolactasia in Sardinians.
Methods

Subjects
Eighty-four Sardinian individuals (63 women and 21 men with a mean age of 39.7713.8 years and a range age of 20-73 years) were chosen from a group of consecutive 832 patients of the ambulatory of digestive pathophysiology of the Brotzu Hospital in Cagliari, Italy, in whom the L-BHT was performed with 25 g of lactose. The 832 patients were divided in two groups: positive (83%) and negative (17%) results according to the above L-BHT. In the design of the study, in order to obtain a similar number of malabsorbers and normal absorbers, a selection was introduced according to the following criteria: (1) age of over 20 years, (2) random selection and (3) availability in participating in the study. When all these three criteria were satisfied, secondary causes of hypolactasia, such as celiac disease, chronic inflammatory bowel disease, intestinal allergies and intestinal parasites, were evaluated and excluded. At the end of this selection an informative number of 43 L-BHT positive individuals (51%) and 41 L-BHT negative individuals (49%) were included in the study and genotyped for the C/T-13910 variant.
Among the 832 patients, clear symptoms after the ingestion of milk were reported in about 24% of cases and in about 18% of the 84 selected patients.
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Genotyping of the lactase C/T-13910 variant
Genomic DNA was isolated from peripheral blood using a salting-out procedure (Miller et al., 1988) and genotyped for the C/T-13910 polymorphism according to Buning et al. (2003) .
Cloning and sequencing
To confirm the results obtained with the PCR-RFLP method, we cloned one PCR reaction of the T and C alleles of the C/T-13910 variant from an heterozygous individual into pGem vector, using the pGEM s -T Easy Vector System I (Promega, Madison, WI, USA) following the manufacturer's instructions. Sequencing reactions were performed in both directions with T7 and M13 primers using Dye Terminator Cycle (Amersham Pharmacia Biotech, Piscataway, NJ, USA) and analyzed with an automated sequencing MegaBACE instrument (Amersham Pharmacia Biotech, Buckinghamshire, UK).
Breath testing
To avoid elevated basal hydrogen production, the day before the test all patients consumed only meals based on rice, meat or fish and olive oil. The evening meal was followed by at least 8 h of fasting time (Corazza et al., 1987) . Before and during the test physical exercise and smoking were not permitted. Sampling of alveolar air was collected by a gasbag, which allows separating the first 500 ml of dead space and the remaining 700 ml of end-alveolar air. To analyze breath samples, a portable hand-held gastrolyzer (EC 60 Bedfont) was utilized. The accuracy of this device was72% of ppm, sensor sensitivity of 1 ppm and response time under 30 s. The gastrolyzer performance and reproducibility have been recently validated in comparison to conventional Quintron Microlyzer (Di Stefano et al., 2003) .
Breath samples were taken at fasting and every 30 min for 4 h after the administration of a solution of 100 or 150 ml of water containing 25 g of lactose (50 g in the repeated tests).
The test was considered positive when H2 values exceeded 20 ppm over the baseline (Metz et al., 1975) .
All patients with a negative result performed a La-BHT to exclude low H2 excretion and to calculate oro-cecal transit by increases of H2 of at least 10 ppm in three consecutive measurements. In detail, a solution containing 18 g of lactulose was utilized and breath samples were taken at fasting and every 15 min for 4 h. Those individuals in whom the increase of H2 did not reach 20 ppm (Corazza et al., 1993) were defined 'low H2-producer'.
Although a combined L-BHT and lactose breath methane test has been proposed to detect false negative results due to low H2-production (Di Stefano et al., 2001) , it was not used in this study because not all low H2-producers show an increased CH4 excretion (Corazza et al., 1994) .
Where appropriate, a symptom score was utilized according previously modified criteria (Di Stefano et al., 2001) . During the test and 24 h after the test, the patients were asked to record intolerance symptoms. Diarrhea, bloating, abdominal pain and flatulence were scored as follows: 0 ¼ absence of the symptoms, 1 ¼ trivial, 2 ¼ mild, 3 ¼ moderate, 4 ¼ strong 5 ¼ severe. The individual scores were summarized and a mean individual value was obtained. The individual maximum score was 5. A critical mean value score X2.25 was considered related with a major severity symptom condition (Di Stefano et al., 2001) .
Data analysis
Sensitivity, specificity and positive and negative predictive values of the genetic test were assessed by a 2 Â 2 table in comparison to the improved test obtained by a combination of different breath tests and clinical assessment.
Results
Among the 84 individuals who performed the L-BHT with 25 g of the lactose, 43 patients had a positive test result (Figure 1 , Group I). As secondary causes of hypolactasia had been excluded, they were considered 'true positives' and thus were not submitted to additional breath tests. Forty-one individuals (Figure 1 , Groups from II to VII) had a negative test result and because it is known that the breath test executed with 25 g of lactose has low sensitivity (Eidsvoll and Schjonsby, 1989) , a new breath test with 18 g of lactulose was performed in these subjects to detect low hydrogen producers. Eleven of the 41 individuals had a negative result indicating a low hydrogen production and were thus excluded from further breath tests (Figure 1 , Groups II and III). With the aim of detecting possible other false negative subjects, the remaining 30 patients (L-BHT: negative with 25 g of lactose and La-BHT: positive) underwent a new breath test with 50 g of lactose (Figure 1 , Groups from IV to VII). In addition, they were asked to report symptoms possibly related to lactose malabsorption during the test and the following night. Twenty-four out of 30 patients had a negative test result with 50 g of lactose (Figure 1 , Groups IV and V and mean symptom score: 1.75) and for this reason they were considered 'true negative'. Among the remaining six patients, five had a positive test result (Figure 1 , Group VI) and a mean symptom score of 2.8 (range: 2.25-3.25), while one patient had a negative test (Figure 1 , Group VII), but manifested clinical symptoms (score: 2.75) indicative of lactose malabsorption.
Thus, lactose malabsorption and lactose normal absorption, determined using the above combination of L-BHT, La-BHT and clinical evaluation, were observed in 49 (Figure 1 , Groups I, VI and VII) and 24 patients (Figure 1 , Groups IV and V) respectively. An additional 11 individuals of the 84 patients were low hydrogen producers (Figure 1 , Groups II and III).
The 49 patients with lactose malabsorption and the 24 with normolactasia were genotyped for the C/T-13910 polymorphism associated with lactase persistence/non-persistence. We found that all the 49 individuals with lactose malabsorption carried the C/C-13910 genotype associated with lactase non-persistence. Among the 24 patients with normolactasia, 23 carried the expected C/T-13910 genotype associated with lactase persistence, but one female had the C/C-13910 genotype (Figure 1, Group V) . The test results of this 'discordant' patient were confirmed after 20 days, repeating the genotyping for the C/C-13910 variant and the L-BHT with 50 g of lactose combined with the symptoms scoring.
In addition, the genetic test was performed also in the eleven low hydrogen producers. Among those, three individuals carried the C/T-13910 and eight the C/C-13910 genotype.
The sensitivity, specificity and positive and negative predictive values of the polymorphism C/T-13910 compared to the improved breath test were 100, 95.8, 98 and 100%, respectively (Table 1) .
The material concerning the symptoms scored, different L-BHT results and genotypes from each subject will be made available upon request to anyone interested as additional material contacting E Schirru at: schirrue@yahoo.it. Genetic testing improves the diagnosis of adult type hypolactasia E Schirru et al
Discussion
The main objective of this work was to verify if in the Sardinian population the C/T-13910 variant might be used, as reported among North-Europeans, to predict adult type hypolactasia. A combination of different breath tests and clinical assessment, better defining the phenotypes of lactose malabsorption and lactose normal absorption, was used to obtain an improved L-BHT test.
The L-BHT and its different modifications are indirect tests and although a series of precautions are usually taken before performing the test, it bears a reasonably high risk for wrong positive and negative results (Simren and Stotzer, 2006) . However, it is considered the most reliable, non-invasive and economical technique by several authors (Bond and Levitt, 1972; Montes and Perman, 1991) and the strategy of improved L-BHT test was preferred in this work because, although jejunal biopsy is considered one of the most reliable methods to detect lactose malabsorbers and many researchers use it as gold standard in comparison studies, it seemed to us too invasive for the diagnosis of such a mild condition as adult type hypolactasia. Also, lactase activity from jejunal biopsies was speculated not to be a gold standard owing to the uneven dissemination of lactase activity throughout the small intestine mucosa (Brummer et al., 1993; Hermans et al., 1997) .
The phenotype of lactose malabsorption was observed in 49 patients, while 24 showed lactose normal absorption. All individuals with a phenotype of lactose malabsorption had the C/C-13910 genotype associated with lactase nonpersistence. Twenty-three out of 24 individuals with a phenotype of lactose normal absorption showed the C/T-13910 genotype associated with lactase persistence while only one had a discordant C/C-13910 genotype.
In Sardinia, the genetic test shows a sensibility of 100% and a specificity of 95.8% with a positive predictive value of 98% and a negative predictive value of 100% (Table 1) , almost overlapping the data obtained in Finnish population where the C/T-13910 variant was found completely associated with lactase activity (Enattah et al., 2002) . Thus, Sardinians show the same genetic association with the C/T-13910 variant of other North-European populations and different from some ethnic groups of sub-Saharan Africa (Mulcare et al., 2004) .
Our findings are in agreement with recent data of the C/T-13910 genotypes in Northern African populations (Myles et al., 2005) .
As far as the discrepancy observed in one individual (30 years and of Sardinian descent) with a lactose normal absorption carrying a lactose non-persistent genotype is concerned, several explanations may account for this divergence: (a) the genetic switch of adult type hypolactasia in rare individuals might be postponed to later in life; (b) the association of lactase non-persistence with the C/T-13910 variant might be not absolute (Poulter et al., 2003) ; (c) the breath test could be falsely negative for unexplained reasons in a normal H2 producer. Indeed, it has been reported that two individuals from Naples carrying the C/C-13910 genotype had a high lactase activity determined by enzyme assay (Swallow, 2003) . In addition to these data from Southern Italy, in some African groups the frequency of the lactasepersistence phenotype is higher than the T allele (Mulcare et al., 2004) . In any case, our findings show that this event is very rare in our Mediterranean population and that the sensibility and specificity of the genetic test is very high.
Genetic testing may complement in several aspects the L-BHT, thus improving the diagnosis of adult type hypolactasia. For instance, genotyping for the C/T-13910 variant may help in identifying low hydrogen producers and therefore reduce false negative results. In addition, the clinician dealing with a patient complaining of symptoms suggestive of lactose intolerance who is a low hydrogen producer and carries a C/C-13910 non-persistent genotype, could suggest a period of lactose-free diet to see possible benefits.
The genetic test can also be very useful in defining those individuals with a borderline value of the L-BHT, that is patients showing values comprised between 10 and 20 ppm of H2 (Veligati et al., 1994) . Indeed, in all these cases the genetic test will provide an unambiguous result permitting to exclude false negative results and avoiding the execution of further tests (La-BTH, lactose methane breath test, L-BHT with 50 g of lactose).
Finally, a diagnosis of secondary causes of hypolactasia may be suspected in subjects with a positive L-BHT carrying the C/T-13910 variant associated with lactase persistence.
In conclusion, the availability of genetic testing for the C/T-13910 variant contributes to an improved diagnosis of adult type hypolactasia providing a very useful complement Numbers used in parameters calculation Groups as reported in Figure 1 Sensitivity 100 49/49*100 (I þ VI þ VII)/(I þ VI þ VII)*100 Specificity 95.8 23/24*100 IV/(IV þ V)*100 PPV 98 49/50*100 (I þ VI þ VII)/(I þ V þ VI þ VII)*100 NPV 100 23/23*100 IV/IV*100
Abbreviations: L-BHT, lactose breath hydrogen; NPV, negative predictive value; PPV, positive predictive value. The validity of the C/T-13910 variant was estimated in comparison with an improved L-BHT. The value of the sensitivity, specificity, PPV and NPV are reported in the second column. The third reports the numbers used to calculate the parameters. The forth column reports the different groups as depicted in Figure 1 .
to the traditional L-BHT. It will also better define the Southern-Europe boundaries of this variant associated with lactase activity.
